首页> 外文期刊>Experimental & translational stroke medicine >Interleukin-18 does not influence infarct volume or functional outcome in the early stage after transient focal brain ischemia in mice
【24h】

Interleukin-18 does not influence infarct volume or functional outcome in the early stage after transient focal brain ischemia in mice

机译:在短暂性局灶性脑缺血后的早期,白介素-18不会影响梗塞体积或功能结局

获取原文
           

摘要

Interleukin-18 (IL-18) is a proinflammatory cytokine of the interleukin-1 family which is upregulated after cerebral ischemia. The functional role of IL-18 in cerebral ischemia is unknown. In the present study, we compared infarct size in IL-18 knock-out and wild-type mice 24 hours and 48 hours after 1-hour transient middle cerebral artery occlusion (tMCAO). Moreover, the functional outcome was evaluated in a modified Bederson score, foot fault test and grip test. There were no significant differences in infarct size or functional outcome tests between wild-type and IL-18 knock-out mice. These data indicate that the early inflammatory response to cerebral ischemia does not involve IL-18, in contrast to other interleukin-1 family members such as interleukin-1.
机译:白介素18(IL-18)是白介素1家族的促炎细胞因子,在脑缺血后被上调。 IL-18在脑缺血中的功能作用尚不清楚。在本研究中,我们比较了1小时瞬时大脑中动脉闭塞(tMCAO)后24小时和48小时的IL-18敲除小鼠和野生型小鼠的梗塞面积。此外,在改良的Bederson评分,足部疲劳测试和抓地力测试中评估了功能结局。在野生型和IL-18基因敲除小鼠之间,梗死面积或功能预后测试无显着差异。这些数据表明,与其他白介素-1家族成员(如白介素-1)相比,对脑缺血的早期炎症反应不涉及IL-18。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号